EGFR and cancer: The cancer-specific receptor selected in our laboratory is HER2 (human epidermal growth factor receptor 2), a member of the EGFR (epidermal growth factor receptor) family, overexpressed in breast, ovary, gastric carcinomas, glioblastomas, etc [40].